Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries
| Main Author: | |
|---|---|
| Publication Date: | 2014 |
| Other Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | eng |
| Source: | Repositório Institucional da FIOCRUZ (ARCA) |
| Download full: | https://www.arca.fiocruz.br/handle/icict/9992 |
Summary: | University of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, Switzerland |
| id |
CRUZ_42ce4e5090650be1aba9a289209d9820 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/9992 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Avila, DoritaAlthoff, Keri NMugglin, CatrinaKaloustian, Kara Wools-Koller, ManuelDabis, FrançoisNash, DenisGsponer, ThomasSungkanuparph, SomnuekMcGowan, CatherineMay, MargaretCooper, DavidChimbetete, CleophasWolff, MarceloCollier, AnnMcManus, HamishDavies, Mary-AnnDominique, CostagliolaRamírez, Brenda CrabtreeChaiwarith, RomaneeCescon, AngelaCornell, MornaDiero, LameckPhanuphak, PraphanSawadogo, AdrienEhmer, JochenEholié, Serge PaulLi, Patrick CKFox, Matthew P.Ghandi, Neel E.González, ElsaLee, Christopher KCHoffmann, Christopher J.Kambugum, AndrewKeiser, OliviaDitangco, RossanaProzesky, HansLampe, FionaKumarasamy, NagalingeswaranKitahata, MariLugina, EmmanuelLyamuya, RitaVonthanak, SaphonnFink, ValeriaMonforte, Antonella d’ArminioLuz, Paula MendesChen, Yi-Ming ArthurMinga, AlbertCasabona, JordiMwango, AlbertChoi, Jun Y.Newell, Marie-LouiseBukusi, Elizabeth A.Ngonyani, KapellaMerati, Tuti P.Otieno, JulianaBosco, Mwebesa B.Phiri, SamNg, Oon T.Anastos, KathrynRockstroh, JürgenSantos, IgnacioOka, ShinichiSomi, GeoffreyStephan, ChristophTeira, RamonWabwire, DeoWandeler, GillesBoulle, AndrewReiss, PeterWood, RobinChi, Benjamin H.Williams, CarolynSterne, Jonathan A.Egger, Matthias2015-04-14T15:13:51Z2015-04-14T15:13:51Z2014AVILA, Dorita et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries. Journal of acquired immune deficiency syndromes, v.65, n.1, p.1–19, 2014.1525-4135https://www.arca.fiocruz.br/handle/icict/999210.1097/QAI.0b013e3182a399791944-7884engLippincott, Williams & WilkinsImmunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countriesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversity of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, SwitzerlandJohns Hopkins Bloomberg School of Public Health. Department of Epidemiology. Baltimore, BC, United States of AmericaUniversity of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, SwitzerlandIndiana University School of Medicine. Indianapolis, IN, United States of AmericaUniversity of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, SwitzerlandUniversité Bordeaux Segalen. Institut de Santé Publique. Epidémiologie et Développement. Bordeaux, BOD, FranceCUNY School of Public Health. New York, NY, United States of AmericaUniversity of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, SwitzerlandMahidol University. Faculty of Medicine Ramathibodi Hospital. Bangkok, BKK, ThailandVanderbilt University School of Medicine. Nashville, TN, United States of AmericaUniversity of Bristol. School of Social and Community Medicine. Bristol, BS, United KingdomThe University of New South Wales. The Kirby Institute. Sydney, SYD, AustraliaNewlands Clinic. Harare, HA, ZimbabweUniversidad de Chile. Fundación Arriarán. Santiago, SA, ChileUniversity of Washington School of Medicine Center. Seattle, SEA, United States of AmericaThe University of New South Wales. The Kirby Institute. Sydney, SYD, AustraliaUniversity of Cape Town. School of Public Health and Family Medicine. Centre for Infectious Disease Epidemiology and Research. Cape Town, CPT, South AfricaUniversity Pierre et Marie Curie. Paris, PAR, FranceInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. México, DF, MéxicoResearch Institute for Health Sciences. Chiang Mai, CNX, ThailandBritish Columbia Centre for Excellence in HIV/AIDS. Vancouver, VAN, CanadaUniversity of Cape Town. School of Public Health and Family Medicine. Centre for Infectious Disease Epidemiology and Research. Cape Town, CPT, South AfricaMoi University. Academic Model Providing Access to Health Care. School of Medicine. Faculty of Health Sciences. Eldoret, EDL, KenyaThe HIV Netherlands Australia Thailand Research Collaboration Red Cross. AIDS Research Centre. Bangkok, BKK, ThailandCHU Sourô Sanou. Bobo-Dioulasso, BOY, Burkina FasoSolidarMed. African HIV prevention and treatment program. Lucerne, QLJ, SwitzerlandService de Maladies Infectieuses et Tropicales. Abidjan, ABJ, Côte d’IvoireQueen Elizabeth Hospital. Hong Kong, HK, ChinaBoston University. Boston University School of Public Health. Center for Global Health and Development. Department of Epidemiology. Boston, BOS, United States of America / University of the Witwatersrand. Health Economics and Epidemiology Research Office. Johannesburg, JHB, South AfricaEmory University Rollins School of Public Health. Global Health & Infectious Diseases. Departments of Epidemiology. Atlanta, ATL, United States of AmericaUniversidad Peruana Cayetano Heredia. Instituto de Medicina Tropical Alexander von Humboldt. Lima, LIM, PeruHospital Sungai Buloh. Sungai Buloh, SGB, MalaysiaAurum Institute. Johannesburg, JHB, South Africa / John Hopkins University School of Medicine, Baltimore, BC, United States of AmericaInfectious Diseases Institute, Kampala, KLA, UgandaUniversity of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, SwitzerlandResearch Institute for Tropical Medicine. Manila, MNL, PhilippinesUniversity of Stellenbosch and Tygerberg Hospital. Division of Infectious Diseases. Cape Town, CPT, South AfricaUniversity College London. Research Department of Infection and Population Health, London, LND, United KingdomYRG Centre for AIDS Research and Education. Chennai, CH, IndiaUniversity of Washington School of Medicine Center. Seattle, SEA, United States of AmericaOcean Road Cancer Institute. Dar-es-Salaam, DAR, TanzaniaMorogoro Regional Hospital. Morogoro, MORO, TanzaniaNational Center for HIV/AIDS. Dermatology & STDs. Phnom Penh, PNH, CambodiaFundación Huésped. Buenos Aires, BA, ArgentinaUniversity of Milan. San Paolo Hospital. Clinic of Infectious Diseases & Tropical Medicine. Milano, MI, ItalyFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, BrasilTaipei Veterans General Hospital and AIDS Prevention and Research Centre. National Yang-Ming University. Taipei, TPE, TaiwanCentre Médical de Suivi de Donneurs de Sang. Abidjan, ABJ, Cote d’IvoireCentre d'Estudis Epidemiològics sobre les ITS i Sida de Catalunya. Badalona, BAD, Spain / CIBER Epidemiología y Salud Pública. Barcelona, BAR, SpainZambian Ministry of Health. Lusaka, LUN, ZambiaYonsei University College of Medicine. Department of Internal Medicine. Division of Infectious Diseases. Seoul, SEL, South KoreaUniversity of KwaZulu-Natal. Africa Centre for Health and Population Studies. Mtubatuba, MTU, South AfricaFamily AIDS Care and Education Services. Kisumu, KIS, KenyaTumbi Regional Hospital. Kibaha, KIB, TanzaniaFaculty of Medicine Udayana University & Sanglah Hospital. Bali, BAL, IndonesiaNyanza Provincial Hospital. Kisumu, KIS, KenyaMbarara University of Science and Technology. ISS Clinic. Mbarara, MBQ, UgandaLighthouse Trust. Lilongwe, LLW, MalawiTan Tock Seng Hospital. Singapore, SI, SingaporeAlbert Einstein College of Medicine. Departments of Medicine and Epidemiology and Population Health. New York, NY, United States of AmericaUniversity Hospital Bonn. Department of Internal Medicine I. Bonn, BNN, GermanyHospital La Princesa. Madrid, MAD, SpainNational Center for Global Health and Medicine. Tokyo, TYO, JapanNational AIDS Control Program. Dar es Salaam, DAR, TanzaniaHIVCENTER am Klinikum der Johann Wolfgang Goethe-Universität. Frankfurt, FFM, GermanyHospital Sierrallana. Torrelavega, TVG, SpainMulago University JHU Collaboration. Kampala, KLA, UgandaBern University Hospital and University of Bern. Department of Infectious Diseases. Bern, BER, SwitzerlandUniversity of Cape Town. School of Public Health and Family Medicine. Centre for Infectious Disease Epidemiology and Research. Cape Town, CPT, South AfricaAcademisch Medisch Centrum bij de Universiteit van Amsterdam. Amsterdam, AMS, The NetherlandsUniversity of Cape Town. Desmond Tutu HIV Centre. Cape Town, CPT, South AfricaCenter for Infectious Disease Research in Zambia. Lusaka, LUN, ZambiaNational Institute of Allergy and Infectious Diseases. Epidemiology Branch Division of AIDS. Maryland, MD, United States of AmericaThe University of New South Wales. The Kirby Institute. Sydney, SYD, AustraliaUniversity of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, Switzerland / University of Cape Town. School of Public Health and Family Medicine. Centre for Infectious Disease Epidemiology and Research. Cape Town, CPT, South AfricaObjective: To describe the CD4 cell count at the start of combination antiretroviral therapy (cART) in low-income (LIC), lower middle-income (LMIC), upper middle-income (UMIC), and high-income (HIC) countries. Methods: Patients aged 16 years or older starting cART in a clinic participating in a multicohort collaboration spanning 6 continents (International epidemiological Databases to Evaluate AIDS and ART Cohort Collaboration) were eligible. Multilevel linear regression models were adjusted for age, gender, and calendar year; missing CD4 counts were imputed. Results: In total, 379,865 patients from 9 LIC, 4 LMIC, 4 UMIC, and 6 HIC were included. In LIC, the median CD4 cell count at cART initiation increased by 83% from 80 to 145 cells/μL between 2002 and 2009. Corresponding increases in LMIC, UMIC, and HIC were from 87 to 155 cells/μL (76% increase), 88 to 135 cells/μL (53%), and 209 to 274 cells/μL (31%). In 2009, compared with LIC, median counts were 13 cells/μL [95% confidence interval (CI): −56 to +30] lower in LMIC, 22 cells/μL (−62 to +18) lower in UMIC, and 112 cells/μL (+75 to +149) higher in HIC. They were 23 cells/μL (95% CI: +18 to +28 cells/μL) higher in women than men. Median counts were 88 cells/μL (95% CI: +35 to +141 cells/μL) higher in countries with an estimated national cART coverage >80%, compared with countries with <40% coverage. Conclusions: Median CD4 cell counts at the start of cART increased 2000–2009 but remained below 200 cells/μL in LIC and MIC and below 300 cells/μL in HIC. Earlier start of cART will require substantial efforts and resources globally.Antiretroviral Therapy, Highly ActiveAntigens, CD4Africa South of the SaharaNorth AmericaWest IndiesCentral AmericaSouth AmericaEuropeAsiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82352https://www.arca.fiocruz.br/bitstream/icict/9992/1/license.txtafbdf7d7a9bcf771a1cc7edf5f618413MD51ORIGINALImmunodeficiency at the start of combination antiretroviral.pdfImmunodeficiency at the start of combination antiretroviral.pdfapplication/pdf390106https://www.arca.fiocruz.br/bitstream/icict/9992/2/Immunodeficiency%20at%20the%20start%20of%20combination%20antiretroviral.pdf94cf0372748d488e18b13ca4c5adb639MD52TEXTImmunodeficiency at the start of combination antiretroviral.pdf.txtImmunodeficiency at the start of combination antiretroviral.pdf.txtExtracted texttext/plain56795https://www.arca.fiocruz.br/bitstream/icict/9992/3/Immunodeficiency%20at%20the%20start%20of%20combination%20antiretroviral.pdf.txt9b8a485a11c8fe55c5d32361f5c0220fMD53icict/99922018-04-04 08:26:30.711oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-04-04T11:26:30Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| title |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| spellingShingle |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries Avila, Dorita Antiretroviral Therapy, Highly Active Antigens, CD4 Africa South of the Sahara North America West Indies Central America South America Europe Asia |
| title_short |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| title_full |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| title_fullStr |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| title_full_unstemmed |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| title_sort |
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries |
| author |
Avila, Dorita |
| author_facet |
Avila, Dorita Althoff, Keri N Mugglin, Catrina Kaloustian, Kara Wools- Koller, Manuel Dabis, François Nash, Denis Gsponer, Thomas Sungkanuparph, Somnuek McGowan, Catherine May, Margaret Cooper, David Chimbetete, Cleophas Wolff, Marcelo Collier, Ann McManus, Hamish Davies, Mary-Ann Dominique, Costagliola Ramírez, Brenda Crabtree Chaiwarith, Romanee Cescon, Angela Cornell, Morna Diero, Lameck Phanuphak, Praphan Sawadogo, Adrien Ehmer, Jochen Eholié, Serge Paul Li, Patrick CK Fox, Matthew P. Ghandi, Neel E. González, Elsa Lee, Christopher KC Hoffmann, Christopher J. Kambugum, Andrew Keiser, Olivia Ditangco, Rossana Prozesky, Hans Lampe, Fiona Kumarasamy, Nagalingeswaran Kitahata, Mari Lugina, Emmanuel Lyamuya, Rita Vonthanak, Saphonn Fink, Valeria Monforte, Antonella d’Arminio Luz, Paula Mendes Chen, Yi-Ming Arthur Minga, Albert Casabona, Jordi Mwango, Albert Choi, Jun Y. Newell, Marie-Louise Bukusi, Elizabeth A. Ngonyani, Kapella Merati, Tuti P. Otieno, Juliana Bosco, Mwebesa B. Phiri, Sam Ng, Oon T. Anastos, Kathryn Rockstroh, Jürgen Santos, Ignacio Oka, Shinichi Somi, Geoffrey Stephan, Christoph Teira, Ramon Wabwire, Deo Wandeler, Gilles Boulle, Andrew Reiss, Peter Wood, Robin Chi, Benjamin H. Williams, Carolyn Sterne, Jonathan A. Egger, Matthias |
| author_role |
author |
| author2 |
Althoff, Keri N Mugglin, Catrina Kaloustian, Kara Wools- Koller, Manuel Dabis, François Nash, Denis Gsponer, Thomas Sungkanuparph, Somnuek McGowan, Catherine May, Margaret Cooper, David Chimbetete, Cleophas Wolff, Marcelo Collier, Ann McManus, Hamish Davies, Mary-Ann Dominique, Costagliola Ramírez, Brenda Crabtree Chaiwarith, Romanee Cescon, Angela Cornell, Morna Diero, Lameck Phanuphak, Praphan Sawadogo, Adrien Ehmer, Jochen Eholié, Serge Paul Li, Patrick CK Fox, Matthew P. Ghandi, Neel E. González, Elsa Lee, Christopher KC Hoffmann, Christopher J. Kambugum, Andrew Keiser, Olivia Ditangco, Rossana Prozesky, Hans Lampe, Fiona Kumarasamy, Nagalingeswaran Kitahata, Mari Lugina, Emmanuel Lyamuya, Rita Vonthanak, Saphonn Fink, Valeria Monforte, Antonella d’Arminio Luz, Paula Mendes Chen, Yi-Ming Arthur Minga, Albert Casabona, Jordi Mwango, Albert Choi, Jun Y. Newell, Marie-Louise Bukusi, Elizabeth A. Ngonyani, Kapella Merati, Tuti P. Otieno, Juliana Bosco, Mwebesa B. Phiri, Sam Ng, Oon T. Anastos, Kathryn Rockstroh, Jürgen Santos, Ignacio Oka, Shinichi Somi, Geoffrey Stephan, Christoph Teira, Ramon Wabwire, Deo Wandeler, Gilles Boulle, Andrew Reiss, Peter Wood, Robin Chi, Benjamin H. Williams, Carolyn Sterne, Jonathan A. Egger, Matthias |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Avila, Dorita Althoff, Keri N Mugglin, Catrina Kaloustian, Kara Wools- Koller, Manuel Dabis, François Nash, Denis Gsponer, Thomas Sungkanuparph, Somnuek McGowan, Catherine May, Margaret Cooper, David Chimbetete, Cleophas Wolff, Marcelo Collier, Ann McManus, Hamish Davies, Mary-Ann Dominique, Costagliola Ramírez, Brenda Crabtree Chaiwarith, Romanee Cescon, Angela Cornell, Morna Diero, Lameck Phanuphak, Praphan Sawadogo, Adrien Ehmer, Jochen Eholié, Serge Paul Li, Patrick CK Fox, Matthew P. Ghandi, Neel E. González, Elsa Lee, Christopher KC Hoffmann, Christopher J. Kambugum, Andrew Keiser, Olivia Ditangco, Rossana Prozesky, Hans Lampe, Fiona Kumarasamy, Nagalingeswaran Kitahata, Mari Lugina, Emmanuel Lyamuya, Rita Vonthanak, Saphonn Fink, Valeria Monforte, Antonella d’Arminio Luz, Paula Mendes Chen, Yi-Ming Arthur Minga, Albert Casabona, Jordi Mwango, Albert Choi, Jun Y. Newell, Marie-Louise Bukusi, Elizabeth A. Ngonyani, Kapella Merati, Tuti P. Otieno, Juliana Bosco, Mwebesa B. Phiri, Sam Ng, Oon T. Anastos, Kathryn Rockstroh, Jürgen Santos, Ignacio Oka, Shinichi Somi, Geoffrey Stephan, Christoph Teira, Ramon Wabwire, Deo Wandeler, Gilles Boulle, Andrew Reiss, Peter Wood, Robin Chi, Benjamin H. Williams, Carolyn Sterne, Jonathan A. Egger, Matthias |
| dc.subject.decs.pt_BR.fl_str_mv |
Antiretroviral Therapy, Highly Active Antigens, CD4 Africa South of the Sahara North America West Indies Central America South America Europe Asia |
| topic |
Antiretroviral Therapy, Highly Active Antigens, CD4 Africa South of the Sahara North America West Indies Central America South America Europe Asia |
| description |
University of Bern. Institute of Social and Preventive Medicine. Finkenhubelweg, BE, Switzerland |
| publishDate |
2014 |
| dc.date.issued.fl_str_mv |
2014 |
| dc.date.accessioned.fl_str_mv |
2015-04-14T15:13:51Z |
| dc.date.available.fl_str_mv |
2015-04-14T15:13:51Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
AVILA, Dorita et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries. Journal of acquired immune deficiency syndromes, v.65, n.1, p.1–19, 2014. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/9992 |
| dc.identifier.issn.none.fl_str_mv |
1525-4135 |
| dc.identifier.doi.none.fl_str_mv |
10.1097/QAI.0b013e3182a39979 |
| dc.identifier.eissn.none.fl_str_mv |
1944-7884 |
| identifier_str_mv |
AVILA, Dorita et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries. Journal of acquired immune deficiency syndromes, v.65, n.1, p.1–19, 2014. 1525-4135 10.1097/QAI.0b013e3182a39979 1944-7884 |
| url |
https://www.arca.fiocruz.br/handle/icict/9992 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Lippincott, Williams & Wilkins |
| publisher.none.fl_str_mv |
Lippincott, Williams & Wilkins |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/9992/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/9992/2/Immunodeficiency%20at%20the%20start%20of%20combination%20antiretroviral.pdf https://www.arca.fiocruz.br/bitstream/icict/9992/3/Immunodeficiency%20at%20the%20start%20of%20combination%20antiretroviral.pdf.txt |
| bitstream.checksum.fl_str_mv |
afbdf7d7a9bcf771a1cc7edf5f618413 94cf0372748d488e18b13ca4c5adb639 9b8a485a11c8fe55c5d32361f5c0220f |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1798324692084326400 |